Daily Energy Expenditure Linked to Health Care Utilization

Share this content:
Daily Energy Expenditure Linked to Health Care Utilization
Daily Energy Expenditure Linked to Health Care Utilization

MONDAY, Feb. 6, 2017 (HealthDay News) -- Lower intensity of peak daily energy expenditure estimated from ambulatory electrocardiographic (ECG) monitoring is associated with increased health care utilization, according to a study published in the Feb. 15 issue of The American Journal of Cardiology.

Jason George, M.D., from Beaumont Health in Royal Oak, Mich., and colleagues estimated average and peak daily energy expenditure in metabolic equivalents (METs) in 843 patients who underwent 24-hour ambulatory ECG monitoring.

The researchers found that the estimated daily average and peak METs were 1.7 ± 0.7 and 5.5 ± 2.1, respectively, in this cohort. Significantly fewer hospital encounters were seen for patients who achieved daily bouts of peak energy expenditure of ≥5 METs, and their median health care costs were nearly 50 percent lower than their counterparts who attained <5 METs. Significant differences were seen in health care costs for patients with body mass index (BMI) ≥30 kg/m² based on whether they achieved <5 or ≥5 METs. Regardless of BMI, there were no significant differences in health care costs for patients who achieved ≥5 METs. Among patients with previous percutaneous coronary intervention, health care costs were lower and there were fewer hospital encounters for those who achieved ≥5 METs versus <5 METs.

"Average and peak daily energy expenditures estimated from ambulatory ECG monitoring may provide useful information regarding health care utilization," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »